Literature DB >> 8795084

GLP-1/GIP chimeric peptides define the structural requirements for specific ligand-receptor interaction of GLP-1.

B Gallwitz1, M Witt, C Morys-Wortmann, U R Fölsch, W E Schmidt.   

Abstract

The gastrointestinal hormones glucagon-like peptide-1 (GLP-1) and gastric inhibitory polypeptide (GIP) strongly stimulate insulin release. Despite their high N-terminal sequence similarity, GLP-1 does not bind to the GIP receptor and vice versa. To characterize the domains required for interaction of the peptide ligands with their specific receptors, we performed displacement studies with various synthetic GLP-1/GIP hybrid peptides on RINm5F insulinoma cells. Displacement of 125I-GIP and 125I-GLP-1 was measured using GLP-1/GIP chimeras which comprised GIP and GLP-1 sequences at different positions. The binding affinity to the GLP-1 receptor was found to be sensitive to GIP-like exchanges in the N-terminal 22 amino acids as well as in positions 13 and 15 (loss of affinity 280-fold to more than 1000-fold). C-terminal substitution of the GLP-1 sequence by GIP diminished the affinity towards the GLP-1 receptor only 20-fold. All hybrid peptides investigated showed minimal binding affinity for the GIP receptor, indicating that the entire GIP-sequence (1-31) is important for receptor recognition. These findings provide insight into the structural requirements for the specific interaction of two important insulinotropic peptides with their specific receptors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8795084     DOI: 10.1016/0167-0115(96)00019-5

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  9 in total

1.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

Review 2.  The pathogenic role of the GIP/GIPR axis in human endocrine tumors: emerging clinical mechanisms beyond diabetes.

Authors:  Daniela Regazzo; Mattia Barbot; Carla Scaroni; Nora Albiger; Gianluca Occhi
Journal:  Rev Endocr Metab Disord       Date:  2020-03       Impact factor: 6.514

3.  Evolutionarily conserved residues at glucagon-like peptide-1 (GLP-1) receptor core confer ligand-induced receptor activation.

Authors:  Mi Jin Moon; Hee Young Kim; Sumi Park; Dong-Kyu Kim; Eun Bee Cho; Cho Rong Park; Dong-Joo You; Jong-Ik Hwang; Kyungjin Kim; Han Choe; Jae Young Seong
Journal:  J Biol Chem       Date:  2011-11-21       Impact factor: 5.157

4.  Crystal structure of the incretin-bound extracellular domain of a G protein-coupled receptor.

Authors:  Christoph Parthier; Martin Kleinschmidt; Piotr Neumann; Rainer Rudolph; Susanne Manhart; Dagmar Schlenzig; Jörg Fanghänel; Jens-Ulrich Rahfeld; Hans-Ulrich Demuth; Milton T Stubbs
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-21       Impact factor: 11.205

5.  Black widow spider alpha-latrotoxin: a presynaptic neurotoxin that shares structural homology with the glucagon-like peptide-1 family of insulin secretagogic hormones.

Authors:  G G Holz; J F Habener
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  1998-10       Impact factor: 2.231

6.  Molecular basis of glucagon-like peptide 1 docking to its intact receptor studied with carboxyl-terminal photolabile probes.

Authors:  Quan Chen; Delia I Pinon; Laurence J Miller; Maoqing Dong
Journal:  J Biol Chem       Date:  2009-10-08       Impact factor: 5.157

Review 7.  New perspectives on exploitation of incretin peptides for the treatment of diabetes and related disorders.

Authors:  Nigel Irwin; Peter R Flatt
Journal:  World J Diabetes       Date:  2015-11-10

8.  Inferring high-confidence human protein-protein interactions.

Authors:  Xueping Yu; Anders Wallqvist; Jaques Reifman
Journal:  BMC Bioinformatics       Date:  2012-05-04       Impact factor: 3.169

9.  A novel glucagon-related peptide (GCRP) and its receptor GCRPR account for coevolution of their family members in vertebrates.

Authors:  Cho Rong Park; Mi Jin Moon; Sumi Park; Dong-Kyu Kim; Eun Bee Cho; Robert Peter Millar; Jong-Ik Hwang; Jae Young Seong
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.